Recent News for PRVL - Prevail Therapeutics Inc.

Date Title
Nov 21 Prevail Therapeutics (PRVL) Investor Presentation - Slideshow
Nov 18 Prevail Therapeutics Announces Appointment of Morgan Sheng, Ph.D., to Board of Directors
Nov 13 74 Biggest Movers From Yesterday
Nov 12 Prevail Therapeutics EPS misses by $0.11
Nov 12 Prevail Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights
Nov 6 Prevail Therapeutics to Participate in Upcoming November Conferences
Oct 31 Hedge Funds Have Never Been This Bullish On Prevail Therapeutics Inc. (PRVL)
Oct 8 The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration
Oct 8 Prevail collaborates with Lonza to develop AAV9 gene therapy programs
Oct 1 Prevail Therapeutics to Present at Upcoming October Conferences
Sep 25 CMTL, LOOP, TXMD and SNX among midday movers
Sep 20 We're Not Very Worried About Prevail Therapeutics's (NASDAQ:PRVL) Cash Burn Rate
Sep 20 The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering
Sep 19 Prevail Therapeutics to join key indexes tomorrow
Sep 19 Prevail Therapeutics Announces Addition to Russell 2000®, 3000® and Microcap® Indexes
Sep 10 Prevail Therapeutics Provides Program Update on PR001 in Parkinson’s Disease with GBA1 Mutations and Neuronopathic Gaucher Disease
Sep 4 Prevail Therapeutics to Present at Morgan Stanley 2019 Global Healthcare Conference
Aug 14 Prevail Therapeutics EPS beats by $0.66
Aug 14 Prevail Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
Aug 12 90 Biggest Movers From Friday
Aug 9 The Daily Biotech Pulse: Vascepa Delay Sends Amarin Reeling, Eidos Jumps On Buyout Offer, Nektar's Bitter Q2
Aug 9 110 Biggest Movers From Yesterday
Aug 8 The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering
Aug 7 Prevail Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference
Jul 15 Analysts Initiate Bullish Coverage Of Prevail Therapeutics
Back to the Main PRVL Page...